IncellDx

The companies will study the combination of their respective technologies for predicting patient responses to metastatic lung cancer immunotherapy.

The kit uses a proprietary non-enzymatic method to prepare intact, single-cell suspensions from tissue in less than 10 minutes.

Single-cell RNA sequencing on thousands of tumor and surrounding cells from 19 melanoma samples revealed subsets of cells with apparent resistance potential.

IncellDx's investigational molecular assay used to quantify HPV E6/E7 mRNA in single cells has been optimized to run on Beckman Coulter's CytoFlex flow cytometry system.

The partners will couple Claremont BioSolutions' enzyme-free tissue homogenization technology with IncellDx's reagents.

IncellDx said this week that it has hired Christine Meda as chief business officer.

Former Life Technologies executive Paul Grossman has joined Telegraph Hill Partners as a venture partner.

NEW YORK (GenomeWeb News) – IncellDx and Bristol-Myers Squibb have signed an agreement to develop a molecular test that may eventually be used as a companion diagnostic to identify best responders to an investigational drug in BMS's pipeline.

NEW YORK (GenomeWeb News) – IncellDx today said it has reached a deal to offer its molecular diagnostic test for human papillomavirus in India.

NEW YORK (GenomeWeb News) – Molecular diagnostics company IncellDx today announced a deal with Chinese esoteric reference laboratory Kindstar Global to offer IncellDx's test for detecting oncogenic human papillomavirus PV E6, E7 messenger RNA in China.

Pages

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.